VRTX

VRTX

Vertex Pharmaceuticals Inc
Biotechnology
$503.25 -0.48% As of Oct 9, 1:40 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

TTM Squeeze Tightens Grip on VRTX at $503.25

Neutral
Oct 9, 2026 at 1:40 AM • $503.25 (-0.48%)

Vertex Pharmaceuticals Inc (VRTX) slipped 0.48% to $503.25 on October 9.

Chart analysis reveals a bearish configuration:

Moving Averages Price sits below both the 9-day ($508.91) and 21-day ($514.79) EMAs, suggesting short-term weakness.
Momentum RSI at 39.2 is in neutral territory. MACD is bearish (-4.88 vs signal -2.89).
Volatility Stock has been in a TTM Squeeze for 5 days, indicating compressed volatility and potential for a significant move.
Key levels to watch: Support at $497.92, Resistance at $530.23.

TTM Squeeze Alert: VRTX Primed for Big Move at $503.25

Neutral
Oct 8, 2026 at 9:01 PM • $503.25 (-0.48%)

Technical Damage Mounts for VRTX at $505.64

Bearish
Oct 8, 2026 at 1:24 AM • $505.64 (+0.67%)

VRTX Drops to $505.64 as EMAs Flash Warning

Bearish
Oct 7, 2026 at 9:01 PM • $505.64 (+0.67%)

VRTX Bears Take Control as Stock Slides to $502.31

Bearish
Oct 6, 2026 at 9:01 PM • $502.31 (-0.24%)
Systematic technical analysis • Updated daily after market close

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Subscribe Now Try Scanner

Market Summary

Current Price $503.25
Daily Change -0.48%
Sentiment Neutral
Sector Biotechnology
Last Updated Oct 9

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.